Skip to Main Content

Paper Details

Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model.
Peritoneal Dialysis International
1
2023
CKD, JAK, JAK1/2, JAK1/2i, Janus kinase 1/2, PCK, PM, SMCZ, STAT, angiotensin, angiotensin receptor, dextrose, fibrosis, glucose, hypervascularity, inflammation, losartan, polycystic, rat, rats
Author NameAffiliation
Sharon G Adlerthe Lundquist Institute at Harbor-university of california los angeles Medical Center
  • 1 - 1

Datasets

Release 1.2